A Case of Intrauterine Growth Restriction in Association with Placental Mesenchymal Dysplasia with Abnormal Placental Lymphatic Development

Placenta

Volumn 30, Issue 7, 2009, Pages 654-657

  Heazell, A E P ^a,b   Sahasrabudhe, N ^b   Grossmith, A K ^b   Martindale, E A ^b   Bhatia, K ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL BLACKBURN HOSPITAL   (United Kingdom)

Author keywords

Intrauterine growth restriction; Lymphangiogenesis; Placental mesenchymal dysplasia

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CELL PROLIFERATION; CLINICAL FEATURE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; LYMPHANGIOGENESIS; OUTCOME ASSESSMENT; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PLACENTAL MESENCHYMAL DYSPLASIA; PRIORITY JOURNAL; TROPHOBLAST;

ADOLESCENT; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; LYMPHATIC SYSTEM; PLACENTA; PLACENTA DISEASES; PREGNANCY; PREGNANCY OUTCOME; ULTRASONOGRAPHY, PRENATAL;

EID: 67349243494     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2009.04.004     Document Type: Article

References (12)

1. Ergaz Z., Avgil M., and Ornoy A. Intrauterine growth restriction-etiology and consequences: what do we know about the human situation and experimental animal models?. Reprod Toxicol 20 3 (2005) 301-322
2. Gardosi J., Kady S.M., McGeown P., Francis A., and Tonks A. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ 331 7525 (2005) 1113-1117 [Epub 2005 Oct 19]
3. Pham T., Steele J., Stayboldt C., Chan L., and Benirschke K. Placental mesenchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise: a report of 11 new cases and a review of the literature. Am J Clin Pathol 126 1 (2006) 67-78
4. Jauniaux E., Nicolaides K.H., and Hustin J. Perinatal features associated with placental mesenchymal dysplasia. Placenta 18 8 (1997) 701-706
5. Arizawa M., and Nakayama M. Suspected involvement of the X chromosome in placental mesenchymal dysplasia. Congenit Anom (Kyoto) 42 4 (2002) 309-317
6. Ny A., Koch M., Vandevelde W., Schneider M., Fischer C., Diez-Juan A., et al. Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles. Blood 112 5 (2008) 1740-1749
7. Bjorndahl M., Cao R., Nissen L.J., Clasper S., Johnson L.A., Xue Y., et al. Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc Natl Acad Sci U S A 102 43 (2005) 15593-15598
8. Robinson W.P., Lauzon J.L., Innes A.M., Lim K., Arsovska S., and McFadden D.E. Origin and outcome of pregnancies affected by androgenetic/biparental chimerism. Hum Reprod 22 4 (2007) 1114-1122
9. H'Mida D., Gribaa M., Yacoubi T., Chaieb A., Adala L., Elghezal H., et al. Placental mesenchymal dysplasia with Beckwith-Wiedemann syndrome fetus in the context of biparental and androgenic cell lines. Placenta 29 5 (2008) 454-460
10. Kaiser-Rogers K.A., McFadden D.E., Livasy C.A., Dansereau J., Jiang R., Knops J.F., et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet 43 2 (2006) 187-192
11. Rogers P.A., Donoghue J.F., and Girling J.E. Endometrial lymphangiogensis. Placenta 29 Suppl A (2008) S48-S54
12. Portmann-Lanz C.B., Schoeberlein A., Huber A., Sager R., Malek A., Holzgreve W., et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol 194 3 (2006) 664-673